Rheumatoid Arthritis: A Deep Dive into Pathophysiology

Rheumatoid arthritis (RA) is a chronic autoimmune disorder primarily affecting the joints, characterized by inflammation of the synovial membrane, leading to pain, swelling, and joint deformities. The pathophysiology involves an imbalance in pro-inflammatory and anti-inflammatory cytokines, particularly TNF-α, IL-1, and IL-6, which drive immune cell infiltration and synovial hyperplasia. This process results in cartilage destruction and bone erosion, mediated by activated fibroblasts and osteoclasts. Systemic effects of RA can include cardiovascular complications, anemia, and fatigue. Understanding the molecular mechanisms of RA has paved the way for targeted therapies, such as biologics, which inhibit specific cytokines or immune pathways, improving disease management and patient outcomes.

1. Rheumatoid Arthritis: A Deep Dive into Pathophysiology This presentation will explore the complex pathophysiology of rheumatoid arthritis, a chronic autoimmune disease that affects millions worldwide. We will delve into the immune and inflammatory pathways involved, examining the role of genetic susceptibilities, triggers, and the propagation of disease. by VAIDEHI VADHVANA Ph.D. Scholar

2. Understanding the Immune-Mediated Inflammatory Disease Immune Activation Rheumatoid arthritis is characterized by an aberrant immune response, where the body's own immune system attacks the joints, leading to inflammation and damage. Inflammatory Pathways The disease involves multiple inflammatory pathways, including the release of cytokines, chemokines, and other mediators that contribute to joint destruction.

3. Histopathological Insights: The Synovium Normal Synovium The synovium is a thin lining that nourishes cartilage and produces joint lubricants. In rheumatoid arthritis, it undergoes significant changes. RA Synovium The synovial lining thickens, and the subintimal area becomes infiltrated with inflammatory cells, leading to pannus formation and joint destruction.

4. Cartilage Degradation: A Hallmark of RA Cartilage, composed of type II collagen and proteoglycans, is normally resilient. In RA, proteolytic enzymes, driven by cytokines like IL-1 and TNF, degrade cartilage, impairing its integrity and water content.

5. Bone Destruction: A Consequence of Osteoclast Activation Bone destruction is a characteristic of RA, primarily driven by the activation of osteoclasts. Cytokines like TNF and IL-1, as well as IL-17, stimulate osteoclast differentiation and bone resorption.

6. Synovial Cavity: A Site of Inflammation The synovial cavity normally contains a small amount of viscous fluid. In RA, large effusions occur, filled with inflammatory cells, primarily neutrophils, contributing to joint pain and swelling.

7. Disease Initiation: Unraveling the Triggers 1 Genetic Susceptibilities The shared epitope in HLA-DR4 is a major genetic risk factor for RA, contributing to approximately 30% of the genetic risk. 2 Triggers of Disease Cigarette smoking is a significant risk factor for RA, particularly in individuals with the shared epitope and RA autoantibodies. 3 The Role of Oral Bacteria Porphyromonas gingivalis, a bacteria associated with periodontal disease, may contribute to citrullination, a key event in RA initiation.

8. Citrullination: A Key Event in RA Citrullination is a post-translational modification of arginine residues in proteins. In RA, autoantibodies develop against citrullinated peptides, leading to an autoimmune response.

9. Propagation of Disease: A Complex Network of Interactions T Cell Activation T cells become activated upon encountering antigen in the context of MHC, leading to proliferation and cytokine production, further driving inflammation. B Cell Activation and Autoantibodies B cells become activated through interactions with T cells and cytokines, differentiating into plasma cells that produce autoantibodies like rheumatoid factors and anti-CCP.

10. Inflammatory Mediators: Orchestrating Joint Destruction Cytokines like TNF, IL-1, and IL-6 play a central role in RA, driving inflammation, cartilage degradation, and bone destruction. Other mediators, including prostaglandins, leukotrienes, and matrix metalloproteinases, contribute to the disease process.

11. THANK YOU